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2208 ABSTRACTSusing standard clonogenic assays, and counting individual colony survival
post-exposure to increasing doses of x-ray radiation. Biological (siRNA)
knockdown of AC was performed, and clonogenic assays were repeated
to establish the impact of AC inhibition on radiosensitivity.
Results: Colorectal cancer cell lines with greater cellular AC protein
expression (LIM 1215/MDST8) demonstrated higher colony survival
compared to lower expressers (HT29/HCT 116) at specific radiation doses.
Titrated siRNA concentrations (40 nMe80 nM) achieved >70% AC
expression reduction. Three cell lines with differential AC expression
(HCT 116/HT 29/LIM 1215) were treated with siRNA for AC. Clonogenic
assays confirmed that siRNA knockdown reduced colony formation effi-
ciency (colonies/number of cells plated e CFE) and improved radiosensi-
tivity across all cell lines. HT29 (0.52 (CFE) control vs 0.13 (CFE)
knockdown at 1 Gy); HCT (0.24 (CFE) control vs 0.09 (CFE) knockdown
at 1 Gy); LIM 1215 (0.88 (CFE) control vs 0.43 (CFE) knockdown at
0.25 Gy).
Conclusion: High AC expression correlates with radio resistance in the
colorectal cancer cell lines studied. In vitro analysis confirmed siRNA
knockdown of AC levels in these cell lines improved their radiosensitivity.
Further work is needed to determine the translational potential of AC to
serve as a novel response biomarker in patients selected to undergo CRT
in colorectal cancer.
https://doi.org/10.1016/j.ejso.2017.10.088
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Background: HPV positive (HPVþ) oropharyngeal squamous cell
carcinomas (OPSCC) are characterised by extensive nodal disease, but
are associated with significantly better outcome than HPV negative
OPSCC. In head and neck SCC, high levels of lactate are associated
with subsequent nodal and distant metastases and a ‘three compartment
tumour metabolism’ model has been proposed in oral cancer. We investi-
gated the metabolic status of HPVþ OPSCC.
Method: The metabolic organization of 50 HPV þve OPSCC was
determined by histopathological staining using antibodies to Ki-67,
TOMM20, MCT4 and MCT1.
Results: High, levels of Ki-67 reactivity were observed in carcinoma
cells at both the tumour centre and the advancing front, but more highly
differentiated cells did not express Ki67. TOMM20 expression was
strongly positive in all carcinoma cells, while CAFs were always more
weakly stained.
High MCT1 expression was observed in all carcinoma cells regardless
of their position within the tumour but was negative or weak in the stromal
compartment. Strong MCT4 immunoreactivity was found in more than 2/3
of carcinoma cells, but the unstained areas did not show consistent local-
isation. MCT4 expression was present at lower intensity in CAFs.
In general, where we observed TOMM20 staining, the cells also ex-
pressed MCT1 and a high proportion of the cells were Ki-67 positive.
Conclusion: We have identified that epithelial cancer cells in HPVþ
OPSCC are highly proliferative, rich in mitochondria and consume mito-
chondrial fuels (Ki-67þ/TOMM20þ/MCT1þ). These proliferating cells
co-exist with a group of non-proliferating stromal cells which express
MCT4. This contrasts with earlier data from oral SCC (Curry et al
2013) where a separate, non-proliferating, catabolic compartment of carci-
noma cells also exists.
In summary, we show that the three-compartment tumour metabolism
model is not present in HPVþ OPSCC, possibly due to the histological
characteristics of these tumours.
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Background: FABPs are a family of 12 cytosolic proteins and their
main function is to transport fatty acids into cells. FABP5 was proved to
play an important role prostate cancer cells. The possible roles of other
FABPs have not been fully studied. In this work, we investigated the
expression status of FABP12 (a newly discovered member of FABPs) in
prostate cancer cells and tissues. The possible promoting role of the
elevated FABP12 in malignant progression was also assessed.
Method: The FABP12 mRNA was measured by qPCR. Western blot
was performed to analyse FABP12 at the protein level. Immunohistochem-
ical attaining was performed to analyze an archival set of benign and ma-
lignant human prostate tissues to assess the expression status of FABP12.
The correlation of the increased FABP12 expression with patient survival
is assessed with Kaplan Meier Survival curve and Log Rank test.
Results: FABP12 expression at both mRNA and protein levels were
increased in malignant cell lines and the FABP12 increase is closely asso-
ciated with increasing degree of malignancy. FABP12 was barely detect-
able in BPH, but its immunohistological staining in prostate carcinomas
was significantly stronger than that in BPH. The staining intensity was
increased as the increasing Gleason scores and the increased FABP12 is
significantly associated with patient survival.
Conclusion:The results showed that FABP12 is overexpressed in highly
malignant prostate cancer cells and tissues. Thus, FABP12 may play an
important promoting role in malignant progression of prostate cancer.
https://doi.org/10.1016/j.ejso.2017.10.091
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Background: In the UK, ductal carcinoma in situ (DCIS) accounts for
one fifth of all screen-detected breast cancers. Risk factors for DCIS have
traditionally been thought to be the same as for invasive breast cancer
(IBC), but few studies have examined this. We compared the effect of
different lifestyle factors on the incidence of these two cancers.
Method:We undertook a prospective cohort study using data from UK
Biobank. We included all women aged 50e69 years enrolled into UK Bio-
bank between 2006 and 2010 from across the UK. We excluded women
with a prior diagnosis of any cancer, except non-melanoma skin cancer.
Women were followed from the date of entry into UK Biobank until the
earliest of DCIS diagnosis, IBC diagnosis, death, loss to follow-up on
31/12/2015.
Results: During our study period, 456 women were diagnosed with
DCIS without prior IBC and 2772 were diagnosed with IBC without prior
DCIS. For both conditions, postmenopausal body mass index (BMI) was
associated with an increased risk, and the number of live births was asso-
ciated with a decreased risk. However, the magnitude of the effects
differed between DCIS and IBC. The effect of postmenopausal BMI
35 kg/m2 was larger for DCIS than for IBC (RR 2.35, 95% CI
1.14e4.82), and the decrease in risk with each additional live birth was
greater for DCIS than for IBC (p ¼ 0.03).
Conclusion: We present the most detailed comparison of risk factors
for DCIS and IBC to date. Our results confirm similarities in the risk fac-
tors for these two conditions, but reveal differences in the magnitude of
their effect. By doing so, these findings provide insights into the contribu-
tion of different factors at different stages in the process of carcinogenesis.
https://doi.org/10.1016/j.ejso.2017.10.092
